Article
Toward “off‐the‐shelf” allogeneic CAR T cells
2020-04-30
Abstract excerpt
Chimeric antigen receptor (CAR) T cell therapy represents a major breakthrough in the field of immuno-oncology. Many potential issues are apparent for autologous CAR T cell therapy, such as time for manufacturing and need for interim therapies in progressing patients, wide variations in terms of quality and quantity of T cells, and difficulty to obtain enough cells for redosing. “Off-the-shelf” allogeneic CAR T ce...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 484b7dfa-c27c-52e5-ac0a-950669f17120
- DOI
- 10.1002/acg2.86
